Insider Trading Alert - CLNE, NVAX And MA Traded By Insiders

 

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

 

Friday, Sept. 26, 2014, 22 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $3,894.00 to $9,906,900.00.

 

Highlighted Stocks Traded by Insiders:

 

Clean Energy Fuels (CLNE) - FREE Research Report

 

Richard R. Wheeler, who is Chief Financial Officer at Clean Energy Fuels, sold 160,444 shares at $8.52 on Sept. 26, 2014. Following this transaction, the Chief Financial Officer owned 0 shares meaning that the stake was reduced by 100% with the 160,444-share transaction.

 On Monday, Sept. 29, 2014, Richard R. Wheeler replaced his position in Clean Energy Fuels by exercising options to buy a total of 170,000 shares for $503,200. The CFO effectively netted $863,247, not including any costs to execute the trades, while increasing his stake in the company.

The shares most recently traded at $8.55, up $0.03, or 0.39% since the insider transaction. Historical insider transactions for Clean Energy Fuels go as follows:

 

  • 4-Week # shares bought: 20,000
  • 12-Week # shares bought: 20,000
  • 12-Week # shares sold: 8,000
  • 24-Week # shares bought: 20,000
  • 24-Week # shares sold: 8,000

 

 

The average volume for Clean Energy Fuels has been 971,700 shares per day over the past 30 days. Clean Energy Fuels has a market cap of $764.0 million and is part of the utilities sector and utilities industry. Shares are down 34.01% year-to-date as of the close of trading on Friday.

 

Clean Energy Fuels Corp. provides natural gas as an alternative fuel for vehicle fleets. It designs, builds, operates, and maintains fueling stations. Currently, there are 3 analysts who rate Clean Energy Fuels a buy, 2 analysts rate it a sell, and 3 rate it a hold.

 

Exclusive Offer: Get the latest Stock Analysis on CLNE - FREE

 

TheStreet Quant Ratings rates Clean Energy Fuels as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, poor profit margins, weak operating cash flow and generally high debt management risk. Get the full Clean Energy Fuels Ratings Report from TheStreet Quant Ratings now.

 

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

 

Novavax (NVAX) - FREE Research Report

 

 

Glenn Gregory M, who is SVP, Research and Development at Novavax, sold 16,809 shares at $4.16 on Sept. 26, 2014. Following this transaction, the SVP, Research and Development owned 0 shares meaning that the stake was reduced by 100% with the 16,809-share transaction.

 

Hahn Timothy Jon, who is SVP, Manufacturing at Novavax, bought 9,000 shares at $4.17 on Sept. 26, 2014. Following this transaction, the SVP, Manufacturing owned 98,656 shares meaning that the stake was boosted by 10.04% with the 9,000-share transaction.

 

The shares most recently traded at $4.13, down $0.04, or 0.97% since the insider transaction. Historical insider transactions for Novavax go as follows:

 

  • 4-Week # shares bought: 51,462
  • 4-Week # shares sold: 29,000
  • 12-Week # shares bought: 51,462
  • 12-Week # shares sold: 29,000
  • 24-Week # shares bought: 73,462
  • 24-Week # shares sold: 29,000

 

 

The average volume for Novavax has been 3.0 million shares per day over the past 30 days. Novavax has a market cap of $989.4 million and is part of the health care sector and drugs industry. Shares are down 18.16% year-to-date as of the close of trading on Friday.

 

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. Currently, there are 4 analysts who rate Novavax a buy, no analysts rate it a sell, and none rate it a hold.

 

Exclusive Offer: Get the latest Stock Analysis on NVAX - FREE

 

TheStreet Quant Ratings rates Novavax as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income and weak operating cash flow. Get the full Novavax Ratings Report from TheStreet Quant Ratings now.

 

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

 

MasterCard (MA) - FREE Research Report

 

MasterCard Foundation, who is 10% Owner at MasterCard, sold 23,679 shares at $75.51 on Sept. 26, 2014. Following this transaction, the 10% Owner owned 118.0 million shares meaning that the stake was reduced by 0.02% with the 23,679-share transaction.

 

The shares most recently traded at $74.03, down $1.48, or 1.99% since the insider transaction. Historical insider transactions for MasterCard go as follows:

 

  • 4-Week # shares sold: 118,395
  • 12-Week # shares sold: 421,834
  • 24-Week # shares sold: 471,132

 

 

The average volume for MasterCard has been 4.1 million shares per day over the past 30 days. MasterCard has a market cap of $83.3 billion and is part of the financial sector and financial services industry. Shares are down 10.16% year-to-date as of the close of trading on Friday.

 

MasterCard Incorporated provides transaction processing and other payment-related services in the United States and internationally. It facilitates the processing of payment transactions, including authorization, clearing, and settlement, as well as delivers related products and services. The stock currently has a dividend yield of 0.59%. The company has a P/E ratio of 27.0. Currently, there are 17 analysts who rate MasterCard a buy, no analysts rate it a sell, and 8 rate it a hold.

 

Exclusive Offer: Get the latest Stock Analysis on MA - FREE

 

TheStreet Quant Ratings rates MasterCard as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full MasterCard Ratings Report from TheStreet Quant Ratings now.

 

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists